NORD's
Washington Office
 Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.
|
|
|
The National Organization for Rare Disorders (NORD) web site, its databases,
and the contents thereof are copyrighted by NORD. No part of the NORD web
site, databases, or the contents may be copied in any way, including but not
limited to the following: electronically downloading, storing in a retrieval
system, or redistributing for any commercial purposes without the express
written permission of NORD. Permission is hereby granted to print one hard
copy of the information on an individual disease for your personal use,
provided that such content is in no way modified, and the credit for the
source (NORD) and NORD’s copyright notice are included on the printed copy.
Any other electronic reproduction or other printed versions is strictly
prohibited.
The information in NORD's Rare Disease Database is for educational purposes only. It
should never be used for diagnostic or treatment purposes. If you have questions regarding
a medical condition, always seek the advice of your physician or other qualified health
professional. NORD's reports provide a brief overview of rare diseases. For more specific
information, we encourage you to contact your personal physician or the agencies listed as
"Resources" on this report.
Copyright 2007
NORD is very grateful to Charis Eng, MD, PhD, Chair and Director, Genomic Medicine Institute, and Director, Center for Personalized Genetic Healthcare, Cleveland Clinic; Professor and Vice Chairman, Department of Genetics, Case Western Reserve University School of Medicine, for assistance in the preparation of this report.
Synonyms of PTEN Hamartoma Tumor Syndrome
Disorder Subdivisions
- Bannayan-Riley-Ruvalcaba Syndrome
- Cowden Disease
- Cowden Syndrome
- Multiple Hamartoma Syndrome
- Proteus-like Syndrome
- Proteus Syndrome
General Discussion
The PTEN hamartoma tumor syndrome (PHTS) is a spectrum of disorders caused by mutations of the PTEN gene. These disorders are characterized by multiple hamartomas that can affect various areas of the body. Hamartoma is a general term for benign tumor-like malformations that can affect any area of the body. Hamartomas are composed of mature cells and tissue normally found in the affected area.
PHTS includes virtually all cases of Cowden syndrome (also known as multiple hamartoma syndrome) and a percentage of cases of Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome and Proteus-like syndrome (i.e., those associated with mutations of the PTEN gene). For more information on Bannayan-Riley-Ruvalcaba syndrome and Proteus syndrome, see NORD’s individual reports on these disorders in the Rare Disease Database.
Cowden syndrome is a difficult to recognize, under-diagnosed genetic disorder characterized by the development of multiple, benign tumor-like malformations (hamartomas) in various areas of the body. Affected individuals also have a predisposition to developing certain cancers, especially cancer of the breast, thyroid or mucous membrane lining the uterus (endometrium). The specific symptoms of Cowden syndrome vary from case to case.
Bannayan-Riley-Ruvalcaba syndrome is characterized by an abnormally large head (macrocephaly), the development of multiple benign growths (hamartomatous polyps) in the intestines (intestinal polyposis), benign tumors just below the skin consisting of fatty tissue (lipomas), and excessive growth before and after birth. Symptoms vary from case to case.
Proteus syndrome is a rare, complex growth disorder characterized by disproportionate overgrowth of various parts of the body. Tissue of the bone, skin, central nervous system and eye and connective tissue are most often affected. The specific symptoms vary greatly from case to case.
The term Proteus-like syndrome is used to describe individuals with significant features of Proteus syndrome, but who fail to meet the specific diagnostic criteria for the disorder, for Cowden syndrome and for Bannayan-Riley-Ruvalcaba syndrome. Germline PTEN mutations have been identified in approximately 50 percent of these cases.
PHTS is inherited as an autosomal dominant trait. The symptoms vary greatly from case to case even among individuals in the same family. In fact, some families have members with Cowden syndrome and others with Bannayan-Riley-Ruvalcaba syndrome. In some cases, the symptoms of the two disorders may occur in the same individual, which is referred to as the Cowden/Bannayan-Riley-Ruvalcaba overlap syndrome. The likelihood of finding a germline PTEN mutation in overlap families is very high (>95%).
Organizations related to PTEN Hamartoma Tumor Syndrome
- American Cancer Society, Inc.
1599 Clifton Road NE
Atlanta GA 30329
Phone #: 404-320-3333
800 #: 800-227-2345
e-mail: N/A
Home page: http://www.cancer.org
- Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg MD 20898-8126
Phone #: 301-251-4925
800 #: 888-205-2311
e-mail: ordr@od.nih.gov
Home page: http://rarediseases.info.nih.gov/Default.aspx
- Madisons Foundation
PO Box 241956
Los Angeles CA 90024
Phone #: 310-264-0826
800 #: N/A
e-mail: getinfo@madisonsfoundation.org
Home page: http://www.madisonsfoundation.org
- March of Dimes Birth Defects Foundation
1275 Mamaroneck Avenue
White Plains NY 10605
Phone #: 914-997-4488
800 #: 888-663-4637
e-mail: Askus@marchofdimes.com
Home page: http://www.marchofdimes.com
- National Alliance of Breast Cancer Organizations
9 East 37th Street
10th Floor
New York NY 10016
Phone #: 212-889-0606
800 #: 888-806-2226
e-mail: nabcoinfo@aol.com
Home page: http://www.nabco.org
- National Cancer Institute
6116 Executive Blvd, MSC 8322, Room 3036A
Bethesda MD 20892-8322
Phone #: 301-435-3848
800 #: 800-422-6237
e-mail: N/A
Home page: http://www.cancer.gov
- Rare Cancer Alliance
1649 North Pacana Way
Green Valley AZ 85614
Phone #: 520-625-5495
800 #: --
e-mail: sharon.lane@rare-cancer.org
Home page: http://www.rare-cancer.org
|
|
